OS THERAPIES INC (OSTX) Stock Income Statement
NYSEARCA:OSTX - NYSE Arca - US68764Y2072 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.18M | 6.81M | 4.34M | 4.45M | 4.84M | |||
| Research and Development | 3.79M | 2.84M | 3.22M | 3.29M | 2.17M | |||
| Selling, General, and Administrative Expenses | 7.40M | 3.97M | 1.13M | 1.15M | 2.66M | |||
| Operating Income | -11.18M | -6.81M | -4.34M | -4.45M | -4.84M | |||
| Interest Income/Expense | -1.22M | -2.05M | -3.45M | -1.81M | -2.58M | |||
| Other Income/Expense | N/A | -17.30K | N/A | N/A | N/A | |||
| Income Before Taxes | -11.30M | -8.88M | -7.79M | -6.25M | -7.42M | |||
| Net Income | -13.27M | -10.89M | -7.92M | -6.38M | -7.51M | |||
| EBITDA | N/A | -6.81M | -4.34M | -4.45M | -4.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.80 | -0.88 | -0.38 | -0.27 | -0.33 | |||
| Statistics | ||||||||
All data in USD